Surveillance of ESBL producing multidrug resistant Escherichia coli in a teaching hospital in India

Asian Pacific Journal of Tropical Disease

Volumn 4, Issue 2, 2014, Pages 140-149

  Rath, Shakti ^a   Dubey, Debasmita ^a   Sahu, Mahesh C ^a   Debata, Nagen K ^a   Padhy, Rabindra N ^a  

^a SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

Author keywords

Community; E. coli; ESBL strains; Infection dynamics; Multidrug resistance; Nosocomial

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; KANAMYCIN; LEVOFLOXACIN; NALIDIXIC ACID; NETILMICIN; NORFLOXACIN; OFLOXACIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; TETRACYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; HOSPITAL INFECTION; INDIA; INTENSIVE CARE; MULTIDRUG RESISTANCE; NEWBORN INTENSIVE CARE; NONHUMAN; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; TEACHING HOSPITAL; WARD;

EID: 84886699259     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(14)60331-5     Document Type: Article

References (44)

1. Borellio SP, Murray RP, Ferike G Topley and Wilson's microbiology and microbial infections. Medical mycology 2010, 1360-1385. Wiley, New York, part V, chapter 52. L. Ajello, R.J. Hay (Eds.).
2. Song KH, Jeon JH, Park WB, Park SW, Kim HB, et al. Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: A retrospective matched case-control study. BMC Infect Dis 2009, 9:41.
3. Rodríguez-Bano J, Pascual A Clinical significance of extended-spectrum β-lactamases. Expert Rev Anti-Infect Ther 2008, 6:671-683.
4. Klein SJ, Lewinson O Bacterial ATP-driven transporters of transition metals: physiological roles, mechanisms of action, and roles in bacterial virulence. Metallomics 2011, 3:1098-1108.
5. Rho H, Shin B, Lee O, Choi YH, Rho J, Lee J Antibiotic resistance profile of bacterial isolates from animal farming aquatic environments and meats in a peri-urban community in Daejeon, Korea. J Environ Monit 2012, 14:1616-1621.
6. Falagas ME, Karageorgopoulos DE Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008, 46:1121-1122.
7. Anonymous. Diarrhoea: Why children are still dying and what can be done. 2009, ISBN 978-92-806-4462-3 (UNICEF), ISBN 978-92-4-159841-5 (NLM classification: WS 312) (WHO).
8. Boschi-Pinto C, Velebit L, Shibuya K Estimating child mortality due to diarrhoea in developing countries. Bull World Health Organ 2008, 86:657-736.
9. Sahu MC, Dubey D, Rath S, Debata NK, Padhy RN Multidrug Resistance of Pseudomonas aeruginosa as known from surveillance of nosocomial and community infections in an Indian teaching hospital. J Pub Health 2012, 20:413-423.
10. Pal BB, Khuntiaa HK, Samal SK, Kar SK, Patnaik B Epidemics of severe cholera caused by El Tor Vibrio cholerae O1 Ogawa possessing the CTXB gene of the classical biotype in Orissa, India. Int J Infect Dis 2010, 14:384-389.
11. Okonko IO, Nkang AO, Eyarefe OD, Abubakar MJ, Ozejele MO, Amusan TA Incidences of multidrug resistant (MDR) organisms in some poultry feeds sold in Calabar metropolis, Nigeria. British J Pharm Toxicol 2010, 1:15-28.
12. Taneja N, Rao P, Arora J, Dogra A Occurrence of ESBL & Amp-C β-lactamases & susceptibility to newer antimicrobial agents in complicated UTI. Indian J Med Res 2008, 127:85-88.
13. Canton R, Morosini MI Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Revs 2011, 35:977-991.
14. Ahmetagic A, Pemberton JM Antibiotic resistant mutants of Escherichia coli K-12 show increases in heterologous gene expression. Plasmid 2011, 65:51-57.
15. Curova K, Kmetova M, Sabol M, Gombosov L, Lazurova I, Siegfried L Enterovirulent E. coli in inflammatory and non-inflammatory bowel diseases. Fol Microbiol 2009, 54:81-86.
16. Fung M, Simpson S, Packer C Identification of innovation in public health. J Pub Health 2011, 33:123-130.
17. El-Mahmood AM, De N, Alo AB Susceptibility of nosocomial Staphylococcus aureus, Escherichia coli and Candida albicans to some antimicrobial drugs routinely used in Adamawa State Hospitals, Nigeria. J Clin Med Res 2010, 2:125-134.
18. Bean DC, Krahe D, Wareham DW Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob 2008, 7:13.
19. Anbumani N, Mallika V Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates from Chennai, South India in 2007. Intr J Med Up 2011, 6:39-43.
20. Taneja J, Mishra B, Thakur A, Dogra V, Loomba P Nosocomial bloodstream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi. J Infect Dev Countr 2010, 4:517-520.
21. Tille P Baily and Scott's diagnostics in Microbiology 2002, Mosby, St. Louis.
22. Eloff JN A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med 1998, 64:711-713.
23. CLSI - Clinical and Laboratory Standards Institute Cephalosporin and aztreonam breakpoint revisions fact sheet. Document M100-S20 2010, CLSI, Wayne, PA.
24. Ko KS, Lee MY, Song JH, Lee H, Jung DS, Jung SI, et al. Prevalence and characterization of extended spectrum β-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diag Microbiol Infect Dis 2008, 61:453-459.
25. Drieux L, Brossier F, Sougakoff W, Jarlier V Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 2008, 14:90-103.
26. Falagas ME, Karageorgopoulos DE Extended-spectrum beta-lactamase-producing organisms. J Hosp Infec 2009, 73:345-354.
27. Oliveira CF, Salla A, Lara VA, Rieger A, Horta JA, Alvers SH Prevalence of extended-spectrum beta-lactamases-producing Microorganisms in nosocomial patients and molecular characterization of the SHV type isolates. Brazilian J Microbiol 2010, 41:278-282.
28. Galvin S, Boyle F, Hickey P, Vellinga A, Morris D, Cormica M Enumeration and characterization of antimicrobial-resistant Escherichia coli bacteria in effluent from municipal, hospital, and secondary treatment facility sources. Appl Environ Microbiol 2010, 76:4772-4779.
29. Fothergill JL, Winstanley C, James CE Novel therapeutic strategies to counter Pseudomonas aeruginosa infections. Exp Rev Anti-infective Ther 2012, 10:219-235.
30. Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, et al. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and non-hospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 2010, 16:129-134.
31. Weber DJ, Rutala WA Central line-associated bloodstream infections: prevention and management. Infect Dis Clin N Am 2011, 25:77-102.
32. Kelesidis T, Karageorgopoulos DE, Kelesidis I, Falagas ME Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from Microbiological and clinical studies. J Antimicrob Chemother 2008, 62:895-904.
33. McMurry LM, Levy SB The Periplasmic protein mppA is not involved in regulation of marA in Escherichia coli. Antimicrob Agents Chemother 2011, 55:4939.
34. Martínez JL, Rojo F Metabolic regulation of antibiotic resistance. FEMS Microbiol Revs 2011, 35:768-789.
35. Riordan JT, Dupre JM, Cantore-Matyi SA, Singh AK, Song Y, Zama S, et al. Alterations in the transcriptome and antibiotic susceptibility of Staphylococcus aureus grown in the presence of diclofenac. Ann Clin Microbiol Antimicrob 2011, 10:30-40.
36. Martínez JL Antibiotics and antibiotic resistance genes in natural environments. Science 2008, 321:365-367.
37. Rawat D, Nair D Extended-spectrum β-lactamases in Gram-negative bacteria. J Glob Infect Dis 2010, 2:263-274.
38. Jacoby GA, Munoz-Price LS The new beta-lactamases. N Engl J Med 2005, 352:380-391.
39. Sharma J, Sharma M, Ray P Detection of TEM & SHV genes in Escherichia coli & Klebsiella pneumoniae isolates in a tertiary care hospital from India. Indian J Med Res 2010, 132:332-336.
40. Majiduddin FK, Palzkill T An Analysis of why highly similar enzymes evolve differently. Genetics 2003, 163:457-466.
41. Peirano G, Costello M, Pitout JD Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int J Antimicrob Agent 2010, 36:19-23.
42. Pitout JD, Gregson DB, Campbell L, Laupland KB Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agent Chemother 2009, 53:2846-2851.
43. Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R, et al. Bacteraemia due to extended-spectrum-beta-lactamase -producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother 2010, 65:333-341.
44. Poirel L, Lagrutta E, Taylor P, Pham J, Nordmann P Emergence of metallo-beta-lactamase NDM-1-producing multidrug resistant Escherichia coli in Australia. Antimicrob Agents Chemother 2010, 54:4914-4916.